GT Biopharma, Inc. Business Finance Contracts & Agreements

136 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to Common Shares Purchase Agreement by and among GT Biopharma, Inc., Five Narrow Lane, L.P., and Bristol Capital, LLC
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
2025
Joinder to Registration Rights Agreement by GT Biopharma, Inc. and Robert A. Marzilli
Joinder Agreements
GT Biopharma, Inc.
Biotechnology
2025
First Amendment to Securities Purchase Agreement by and among GT Biopharma, Inc. and Purchasers (including Robert A. Marzilli)
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
2025
Common Shares Purchase Agreement between GT Biopharma, Inc. and Five Narrow Lane, L.P. and Bristol Capital, LLC
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2025
Registration Rights Agreement between GT Biopharma, Inc. and Purchasers dated May 12, 2025
Registration Rights Agreements
GT Biopharma, Inc.
Biotechnology
2025
Securities Purchase Agreement between GT Biopharma, Inc. and Purchasers dated May 12, 2025
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2025
Placement Agency Agreement between GT Biopharma, Inc. and Roth Capital Partners, LLC (2025)
Underwriting Agreements
GT Biopharma, Inc.
Biotechnology
NY
2025
Securities Purchase Agreement between GT Biopharma, Inc. and Purchasers (2025)
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2025
Placement Agency Agreement between GT Biopharma, Inc. and Roth Capital Partners, LLC (May 21, 2024)
Underwriting Agreements
GT Biopharma, Inc.
Biotechnology
NY
2024
Securities Purchase Agreement between GT Biopharma, Inc. and Purchasers dated May 20, 2024
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2024
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
GT Biopharma, Inc.
Biotechnology
2023
Securities Purchase Agreement between GT Biopharma, Inc. and Purchasers (December 2022)
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2023
Securities Purchase Agreement between GT Biopharma, Inc. and Purchasers (2020)
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2021
Securities Purchase Agreement between GT Biopharma, Inc. and Purchasers (December 2020/January 2021 Notes)
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2021
Underwriting Agreement between GT Biopharma, Inc. and Roth Capital Partners, LLC (2021)
Underwriting Agreements
GT Biopharma, Inc.
Biotechnology
NY
2021
Second Amendment and Extension of Standstill and Forbearance Agreement between GT Biopharma, Inc. and Lender
Forbearance Agreements
GT Biopharma, Inc.
Biotechnology
2021
Pre-Funded Warrant to Purchase Common Stock between GT Biopharma, Inc. and Holder (May 15, 2025)
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
NY
2025
Common Stock Purchase Warrant Agreement between GT Biopharma, Inc. and Holder (May 12, 2025)
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2025
GT Biopharma, Inc. Common Stock Vesting Warrant Agreement (May 12, 2025)
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2025
Pre-Funded Common Stock Purchase Warrant between GT Biopharma, Inc. and Cytovance Biologics, Inc.
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2025
Series B Common Stock Purchase Warrant Agreement between GT Biopharma, Inc. and Holder
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
NY
2025
Series A Common Stock Purchase Warrant Agreement between GT Biopharma, Inc. and Holder
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
NY
2025
GT Biopharma, Inc. Inducement Offer to Exercise Common Stock Purchase Warrants Agreement (February 2025)
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2025
Placement Agent Common Stock Purchase Warrant between GT Biopharma, Inc. and Placement Agent
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
NY
2025
Pre-Funded Common Stock Purchase Warrant Agreement between GT Biopharma, Inc. and Holder
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
NY
2025
Common Stock Purchase Warrant Agreement between GT Biopharma, Inc. and Holder
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
NY
2025
Common Stock Purchase Warrant Agreement between GT Biopharma, Inc. and Holder (May 2024)
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2024
Placement Agent Common Stock Purchase Warrant between GT Biopharma, Inc. and H.C. Wainwright & Co., LLC
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2023
Pre-Funded Common Stock Purchase Warrant between GT Biopharma, Inc. and Holder (January 2023)
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2023
Common Stock Purchase Warrant Agreement between GT Biopharma, Inc. and Holder (2023)
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2023
GT Biopharma, Inc. Form of December 2020 / January 2021 Convertible Note Agreement
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2021
Amendment to Convertible Note between GT Biopharma, Inc. and Alto Opportunity Master Fund, SPC
Note Agreements
GT Biopharma, Inc.
Biotechnology
2021
GT Biopharma, Inc. Form of December 2020 / January 2021 Convertible Note Agreement
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2021
Amendment to Convertible Note between GT Biopharma, Inc. and Alto Opportunity Master Fund, SPC
Modification Agreements
GT Biopharma, Inc.
Biotechnology
2021
GT Biopharma, Inc. Pre-Funded Warrant to Purchase Common Stock (Form of Warrant)
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
NY
2021
GT Biopharma, Inc. Warrant to Purchase Common Stock (Form of Warrant)
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
NY
2021
Amendment to Convertible Note between GT Biopharma, Inc. and Holder (Effective January 2021)
Modification Agreements
GT Biopharma, Inc.
Biotechnology
2021
GT Biopharma, Inc. $500,000 Convertible Note Due January 31, 2021 with Alto Opportunity Master Fund
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Amendment to Convertible Note and Standstill Agreement between GT Biopharma, Inc. and Note Holder
Note Agreements
GT Biopharma, Inc.
Biotechnology
2020
Convertible Settlement Note Agreement between GT Biopharma, Inc. and Theorem Group, LLC (Due January 31, 2021)
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020